Discharge Management for COPD Exacerbation

Introduction to Discharge Regimen

The American Thoracic Society recommends discharging patients with COPD exacerbation on salbutamol MDI with spacer at 2 puffs (200 mcg) every 2-4 hours as needed, ensuring they have been stable on this regimen for at least 24-48 hours before leaving the hospital 1, 2

The European Respiratory Society suggests switching from nebulizer to MDI with spacer at least 24-48 hours before discharge to confirm clinical stability on the discharge regimen 3, 2
The American College of Chest Physicians recommends prescribing salbutamol (albuterol) MDI at 2 puffs (90-100 mcg per puff) every 2-4 hours as needed for symptom relief 4, 5, 1

The American College of Cardiology and other societies emphasize the importance of verifying and documenting proper MDI technique before the patient leaves, as incorrect technique is a major cause of treatment failure 1, 2
The patient must demonstrate correct spacer use, including slow deep inhalation, 5-second breath hold, and waiting 30-60 seconds between puffs 2
Recording FEV1 before discharge is necessary to establish a baseline for future comparison 3
Checking arterial blood gases on room air is recommended if the patient presented with hypercapnic respiratory failure or significant hypoxemia 3, 2

The European Respiratory Society recommends completing a 10-14 day course of oral prednisone 30-40 mg daily if systemic corticosteroids were initiated during hospitalization 4, 5, 1
Corticosteroids can be stopped abruptly after 7-14 days unless there are specific indications for long-term use 3

The Infectious Diseases Society of America suggests ensuring the patient completes a 5-7 day course of antibiotics if started for purulent sputum or increased sputum volume 1
Antibiotics typically do not need to continue beyond 7 days 3

Clinical stability criteria that must be met include the patient being stable on discharge medications for a minimum of 24 hours, less dyspnea, improved oxygen saturation, and better peak expiratory flow 2, 3
Schedule follow-up within 30 days of discharge to reduce readmission risk 1
Reassess oxygen requirements 4-6 weeks post-discharge if oxygen was initiated during hospitalization 2

Do not discharge before 24 hours of stability on MDI therapy, as this significantly increases relapse and readmission risk 2
Do not continue nebulizers at home unless there is a specific documented indication; MDI with spacer is equally effective and more practical 1
Do not skip the inhaler technique verification, as poor technique is a leading preventable cause of treatment failure 1, 2
Do not continue oxygen therapy without physiological reassessment if it was started during the acute phase, as many patients will no longer meet criteria once stabilized 4, 2